WAGNER CHARLES F JR (EVP and CFO) sold 20.2% of their position (9.53K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $4.39M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/8/2026ACC: 0000875320-26-000002
Officer· EVP and CFO
Since Apr 2019
-9.53K
Net shares
Net seller
$4.39M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
9.53K acquired · 19.06K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.53K
Price / share
$189.38
Trade value
$1.81M
% of position
25.3%
1/6/2026
37.73K→47.26K
Common Stock
Direct
Shares
−9.53K
Price / share
$461.00
Trade value
$4.39M
% of position
20.2%
1/6/2026
47.26K→37.73K
Total
Net shares
+0.00
Net value
-$2.59M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/6/2026 | M · Option Exercise | +9.53K | $189.38 | $1.81M | 25.3% | 37.73K | 47.26K |
| Common Stock Direct | 1/6/2026 | S · Sale | −9.53K | $461.00 | $4.39M | 20.2% | 47.26K | 37.73K |
| Total | +0.00 | -$2.59M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
9.53K shares
Shares
−9.53K
Strike price
189.38
Held after
0.00
Exercisable
—
1/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock9.53K shares | 1/6/2026 | M · Option Exercise | −9.53K | 189.38 | — | 0.00 |